Sunitinib in combination with docetaxel and prednisone in chemotherapy-naive patients with metastatic, castration-resistant prostate cancer: a phase 1/2 clinical trial ‡
Titel:
Sunitinib in combination with docetaxel and prednisone in chemotherapy-naive patients with metastatic, castration-resistant prostate cancer: a phase 1/2 clinical trial ‡
Auteur:
Zurita, A.J. George, D.J. Shore, N.D. Liu, G. Wilding, G. Hutson, T.E. Kozloff, M. Mathew, P. Harmon, C.S. Wang, S.L. Chen, I. Chow Maneval, E. Logothetis, C.J.